Literature DB >> 35673499

Assessment of resveratrol on diabetes of zebrafish (Danio rerio).

Mina Faal1, Hamed Manouchehri1, Reza Changizi1, Fatemeh Bootorabi2, Mohammad Reza Khorramizadeh3.   

Abstract

Purpose: Zebrafish (Danio rerio) is an established model for studying various metabolic diseases. The aim of this study was to evaluate the effect of resveratrol as a natural polyphenol on reducing inflammation caused by hyperglycemia (diabetes) and its effect on digestive tissue as well as TNF-α, IFN-γ, and INL1β genes in zebrafish.
Methods: Within a 20-day period, the research was performed on 120 adult zebrafish, which were randomly classified into eight groups: two experimental treatments (induced glucose = +G) and (without glucose = -G), where each main group was as follows: CTRL = control and RSV resveratrol with doses 10, 20, and 30 μmol/L. At the end of the period, the blood glucose level was measured using glucose test strip, staining of intestinal tissue was done by hematoxylin and eosin (H&E), and expression of INF-γ, IL1-β, and TNF-α genes extracted from the intestinal was measured via internal method RT-PCR. Data analysis in this study was performed using SPSS software version 21. One-way ANOVA and mean comparison of treatments by Duncan test were used for data analysis. All statistical analyses were performed at a significant level (P < 0.5) where the mean data were presented with standard deviation.
Results: According to the results, the lowest blood sugar level at the end of the experiment belonged to the group (G-RSV20) where no significant difference was observed between treatments (P > 0.05). The highest expression of IL1-β gene belonged to the (G + CTRL) group (P < 0.05), while the (G + RSV20) group showed the lowest expression of the INF-γ gene and had a significant difference with other groups (P < 0.05). In (G + RSV10) treatment, the lowest expression of TNF-α gene was observed and there was no significant difference with other treatments (P > 0.05). Resveratrol would improve the absorption of nutrients in the intestinal tissue by increasing the number of goblet cells as well as the width and height of the villi.
Conclusion: Collectively, this study indicated that treatment with resveratrol could improve metabolic-mediated performances by reducing blood glucose, increasing food absorption in the intestine tissue, and reducing the expression of inflammatory genes in type 2 diabetic zebrafish model. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  Anti-inflammation; Diabetes mellitus; Gene expression; Hyperglycemia; Resveratrol; Zebrafish

Year:  2022        PMID: 35673499      PMCID: PMC9167402          DOI: 10.1007/s40200-021-00964-3

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  56 in total

1.  Morphology and histochemistry of the digestive tract in carnivorous freshwater Hemisorubim platyrhynchos (Siluriformes: Pimelodidae).

Authors:  Claudemir Kuhn Faccioli; Renata Alari Chedid; Antônio Carlos do Amaral; Irene Bastos Franceschini Vicentini; Carlos Alberto Vicentini
Journal:  Micron       Date:  2014-04-01       Impact factor: 2.251

2.  Impact of molecular charge on GLUT-specific cellular uptake of glucose bioprobes and in vivo application of the glucose bioprobe, GB2-Cy3.

Authors:  Jongmin Park; Jung In Um; Ala Jo; Jinho Lee; Da-Woon Jung; Darren R Williams; Seung Bum Park
Journal:  Chem Commun (Camb)       Date:  2014-08-25       Impact factor: 6.222

3.  Performance, gut morphology and carcass characteristics of fattening rabbits as affected by particle size of pelleted diets.

Authors:  Vincenzo Tufarelli; Salvatore Desantis; Sara Zizza; Vito Laudadio
Journal:  Arch Anim Nutr       Date:  2010-10       Impact factor: 2.242

4.  Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity.

Authors:  E Nisoli; L Briscini; A Giordano; C Tonello; S M Wiesbrock; K T Uysal; S Cinti; M O Carruba; G S Hotamisligil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.

Authors:  Noriko Satoh-Asahara; Yousuke Sasaki; Hiromichi Wada; Mayu Tochiya; Azusa Iguchi; Reiko Nakagawachi; Shinji Odori; Shigeo Kono; Koji Hasegawa; Akira Shimatsu
Journal:  Metabolism       Date:  2012-10-11       Impact factor: 8.694

6.  Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.

Authors:  Forouzan Faghihzadeh; Peyman Adibi; Rahmatollah Rafiei; Azita Hekmatdoost
Journal:  Nutr Res       Date:  2014-09-23       Impact factor: 3.315

7.  Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.

Authors:  Chih-Chun Chang; Chieh-Yu Chang; Yang-Tzu Wu; Jiung-Pang Huang; Tzung-Hai Yen; Li-Man Hung
Journal:  J Biomed Sci       Date:  2011-06-23       Impact factor: 8.410

Review 8.  Fishing for Nature's Hits: Establishment of the Zebrafish as a Model for Screening Antidiabetic Natural Products.

Authors:  Nadia Tabassum; Hongmei Tai; Da-Woon Jung; Darren R Williams
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-23       Impact factor: 2.629

9.  Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages.

Authors:  Mangesh Morey; Peadar O'Gaora; Abhay Pandit; Christophe Hélary
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

10.  Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis.

Authors:  Jing Yang; Geoffrey D Holman
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

View more
  1 in total

1.  Resveratrol Improves the Digestive Ability and the Intestinal Health of Siberian Sturgeon.

Authors:  Shiyong Yang; Wenqiang Xu; Langkun Feng; Chaoyang Zhang; Chaozhan Yan; Jiajin Zhang; Jiansheng Lai; Taiming Yan; Zhi He; Xiaogang Du; Zongjun Du; Wei Luo; Xiaoli Huang; Jiayun Wu; Yunkun Li
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.